General Analysis of Mycobacterium Tuberculosis and its repercussion on the Covid-19 pandemic: A Literature Review
DOI:
https://doi.org/10.33448/rsd-v11i4.26758Keywords:
Tuberculosis; Covid-19; Pandemic.Abstract
Developmental viral infections have led to pandemics, causing large-scale morbidity and mortality. Tuberculosis and the important COVID-19 have characteristics that predispose cross-sectional control exercises. Both are infectious diseases that could be happening together in the human body. In this context, the objective of the study was to carry out a review of the literature regarding the relationship between Mycobacterium Tuberculosis and the Sars-CoV-12 virus during the pandemic. As a methodological approach, articles published between 2021 and 2021 were used, which are only available in the following databases: Virtual Health Library (BVS), LILACS/Pub, SciELO and Google Scholar. Tuberculosis and Covid-19 are comprehensive warnings with their high transmissibility. They are similar diseases that have specific characteristics. Despite the severity of the Sarv-cov-2 virus acting together with tuberculosis, it remains a concern, mainly because it affects social minorities worldwide, generating social problems such as inequality and social exclusion. Because they are altered diseases and manifest as aerosols, it is necessary to adopt protective measures such as the use of mask and social distance in order to prevent these diseases. It is concluded that since the beginning of the coronavirus pandemic, cases of tuberculosis and COVID-19 have occurred simultaneously, and the diagnosis is difficult to perform due to the proximity of signs and symptoms between these diseases.
References
Antonio-Arques, V., Franch-Nadal, J., & Caylà, J. A. (2021). Diabetes y tuberculosis: una sindemia complicada por la COVID-19. Medicina Clinica, 157(6), 288–293.
Bouaré, F. et al. (2020). Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin. Pan African Medical Journal., 35(2).
Campos, H. S. (2021). Mycobacterium tuberculosis resistente: de onde vem a resistência? Bol. Pneumol. Sanit, 7(1), 51-64.
Crisan-Dabija, R. et al. (2020). Tuberculose e COVID-19: lições dos surtos virais anteriores e possíveis resultados futuros. Canadian Respiratory Journal, 2020.
Da Silva, M. E. N. (2018). Aspectos gerais da tuberculose: uma atualização sobre o agente etiológico e o tratamento. RBAC, 50(3), 228-32.
Duarte, R. et al. (2021). Doenças diferentes, mesmos desafios: Determinantes sociais da tuberculose e COVID-19. Pneumologia, 27(4), 338-344.
Ehrt, S., Schnappinger, D., & Rhee, K. Y. (2018). Princípios metabólicos de persistência e patogenicidade em Mycobacterium tuberculosis. Nature Reviews Microbiology, 16(8), 496-507.
Focaccia, R. (2015). Veronesi: tratado de infectologia. Editora Atheneu.
Gonçalves, H. (2000). A tuberculose ao longo dos tempos. História, Ciências, Saúde-Manguinhos, 7(2), 305–327.
González-Domenech, C. M., Pérez-Hernández, I., Gómez-Ayerbe, C., Viciana Ramos, I., Palacios-Muñoz, R., & Santos, J. (2021). Uma pandemia dentro de outras pandemias. quando ocorre uma infecção múltipla de um hospedeiro: SARS-CoV-2, HIV e Mycobacterium tuberculosis. Vírus, 13(5), 931.
Gopalaswamy, R., & Subbian, S. (2021). Corticosteroids for COVID-19 therapy: potential implications on tuberculosis. International journal of molecular sciences, 22(7), 3773.
Hopewell, P. C., Reichman, L. B., & Castro, K. G. (2021). Parallels and mutual lessons in tuberculosis and COVID-19 transmission, prevention, and control. Emerging Infectious Diseases, 27(3), 681.
Jain, V. K., et al. (2020). Tuberculose na era do COVID-19 na Índia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1439-1443.
Kozakevich, G. V.; & Da Silva, R. M. (2015). Tuberculose: Revisão de literatura. Arq. Catarin Med., 44(4), 34-47.
Lopes, A. J.; Jansen, J. M.; & Capone, D. (2006). Patogenia e Imunologia. Revista do Hospital Universitário Pedro Ernesto – UERJ, 5(2), 27-34.
Malik, Y. S. et al. (2020). Vacina BCG: uma esperança para controlar a pandemia de COVID-19 em meio a uma crise. Human Vaccines & Immunotherapeutics, 16(12), 2954-2962.
Milgliori, G. B. et al. (2021). Tuberculose, COVID-19 e admissão hospitalar: consenso sobre prós e contras com base na revisão das evidências. Pneumologia, 27(3), 248–256.
Mishra, A., & Surolia, A. (2018). Mycobacterium tuberculosis: surviving and indulging in an unwelcoming host. IUBMB life, 70(9), 917-925.
Monteiro, P. H. T., et al. (2003). Formação do cordão e morfologia da colônia para a identificação presuntiva do complexo Mycobacterium tuberculosis. Jornal Brasileiro de Microbiologia, 34(2).
Mulale, U. K. et al. (2021). Coinfecção fatal de SARS-CoV-2 e Mycobacterium tuberculosis em uma criança: percepções de Botswana. BMJ Case Reports CP, 14(4), e239701.
Netto, R. G. F., & do Nascimento Corrêa, J. W. (2020). Epidemiologia do surto de doença por coronavírus (COVID-19). Desafios-Revista Interdisciplinar da Universidade Federal do Tocantins, 7(Especial-3), 18-25.
ONG, Catherine Wei Min et al. (2020). Infecções virais epidêmicas e pandêmicas: impacto na tuberculose e no pulmão: um consenso da Associação Mundial para Doenças Infecciosas e Doenças Imunológicas (WAidid), Rede Global de Tuberculose (GTN) e membros do Grupo de Estudo da Sociedade Europeia de Microbiologia Clínica e Doenças Infecciosas para infecções micobacterianas (ESGMYC). European Respiratory Journal, 56(4).
World Health Organization. (2013). Global tuberculosis report 2013. World Health Organization.
Vieira, L. M. F., Emery, E., & Andriolo, A. (2020). COVID-19-Diagnóstico Laboratorial para Clínicos.
Silva, D. R., Mello, F. C. D. Q., D’Ambrosio, L., Centis, R., Dalcolmo, M. P., & Migliori, G. B. (2021). Tuberculose e COVID-19, o novo dueto maldito: quais as diferenças entre Brasil e Europa? Jornal Brasileiro de Pneumologia, 47.
Subramanian, N. et al. (2021). Imagem como modalidade diagnóstica alternativa em um caso presuntivo de TB abdominopélvica em paciente COVID-19. BMJ Case Reports CP, 14(3), e241882.
Tale, S.; & Meitei Soibam, P. (2021). Cuidado dos pacientes com tuberculose na época do COVID-19. Indian Journal of Tuberculosis, 68(2), 285–286.
Tavares, C. M., Cunha, A. M. S. D., Gomes, N. M. C., Lima, A. B. D. A., Santos, I. M. R. D., Acácio, M. D. S., & Souza, C. D. F. D. (2020). Tendência e caracterização epidemiológica da tuberculose em Alagoas, 2007-2016. Cadernos Saúde Coletiva, 28, 107-115.
Coronel Teixeira, R., Aguirre, S., & Pérez Bejarano, D. (2021). Thinking about tuberculosis in times of COVID‐19. Journal of Internal Medicine, 289(4), 589-590.
Udwadia, Z. F., Vora, A., Tripathi, A. R., Malu, K. N., Lange, C., & Raju, R. S. (2020). COVID-19-Tuberculosis interactions: When dark forces collide. indian journal of tuberculosis, 67(4), S155-S162.
Visca, D. et al. (2021). Tuberculose e interação COVID-19: Uma revisão dos efeitos biológicos, clínicos e de saúde pública. Pneumologia, 27(2), 151–165.
Yadav, S.; & Rawal, G. (2020). O caso de tuberculose pulmonar com COVID-19 em um homem indiano - o primeiro de seu tipo já relatado no Sul da Ásia. The Pan African Medical Journal, 36(374).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Arthur Galvão Rodrigues Costa; Carlos Eduardo Rodrigues Cavalcanti; Isadora Maria Lucena Nunes; Talita Saraiva Pimenta; Maria do Socorro Vieira Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
